We are live on ! Find out more
ACER

Acer Therapeutics Inc

Delisted

ACER was delisted on the 8th of November, 2023.

31 hedge funds and large institutions have $3.4M invested in Acer Therapeutics Inc in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

47% more capital invested

Capital invested by funds: $2.32M → $3.4M (+$1.08M)

11% more funds holding

Funds holding: 2831 (+3)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $49K

Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
8
Reduced
4
Closed
6
Calls
Puts
$49K
Net Calls
-$49K
Net Calls Change
-$38K
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$57 +$18 +22 +46%
JWA
27
JFS Wealth Advisors
Pennsylvania
$20
TIM
28
Thompson Investment Management
Wisconsin
$8
Morgan Stanley
29
Morgan Stanley
New York
$1 -$608 -740 -100%
Hudson Bay Capital Management
30
Hudson Bay Capital Management
Connecticut
-$253K -274,300 Closed
AFM
31
Anson Funds Management
Texas
-$120K -129,795 Closed
Renaissance Technologies
32
Renaissance Technologies
New York
-$95K -102,552 Closed
Goldman Sachs
33
Goldman Sachs
New York
-$81.3K -88,054 Closed
Bank of New York Mellon
34
Bank of New York Mellon
New York
-$9.5K -10,290 Closed
Citadel Advisors
35
Citadel Advisors
Florida
-$3.1K -3,359 Closed
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
-$252 -306 -45%

ACER Hedge Fund Activity: Q3 2023 in Review

31 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2023, worth a combined $3.4M — up 47% from $2.32M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ACER positions and 6 closed out — a net gain of 3 holders — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Yakira Capital Management, opening a new position worth an estimated $815K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $253K sold.

  • 31 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2023, up from 28 in Q2 2023.
  • Funds reported $3.4M of Acer Therapeutics Inc stock for Q3 2023, up 47% quarter-over-quarter.
  • 9 funds opened new Acer Therapeutics Inc positions in Q3 2023 and 6 closed out, a net change of +3 holders.
  • The largest Acer Therapeutics Inc buyer in Q3 2023 was Yakira Capital Management, an estimated $815K added.
  • The largest Acer Therapeutics Inc seller in Q3 2023 was Hudson Bay Capital Management, an estimated $253K sold.

Based on aggregated 13F filings for Q3 2023.